In all the in vivo experimental models, p32-CAR T cells induced the regression of GBM growth, and it is important to highlight that this effect was assessed on endogenous levels of p32 expression, no overexpression or ex vivo modifications were performed to the transplanted glioma cells. The gene discussed is C1QBP; the disease is central nervous system cancer.